Skip to main content

Advertisement

SpringerLink
Log in

Excess weight and associated risk factors in patients with systemic lupus erythematosus

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The objective of this study is to determine the socio-demographic, clinical and laboratory characteristics of outpatients with SLE who present with excess weight as well as to assess the immunosuppressive therapy used. One hundred and seventy women with SLE were evaluated consecutively in a transversal study. The relationship between excess weight and the patients’ characteristics was evaluated using univariate and multivariate Poisson regression analysis. Of the 170 patients evaluated, 109 presented with excess weight, two were malnourished and 59 were classified as eutrophic. Age and disease duration of those with excess weight were 42.4 ± 8.7 and 10.4 ± 6.2 years, respectively. Risk factors associated with excess weight were the following: age ≥40 years, <8 years of education, lack of occupation, damage index ≥1, systemic high blood pressure, diabetes mellitus and triglycerides ≥150 mg/dL levels. The use of antimalarial therapy and steroids was associated with a lower frequency of excess weight. Age ≥40 years and the non-usage of methotrexate were the variables independently associated with excess weight in the multivariate analysis. Patients with SLE who have excess weight present distinct clinical-laboratory findings, socio-demographic characteristics and treatment options when compared to normal weight patients. Prospective studies should assess whether these characteristics will interfere with the outcome or prognosis of lupus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization. Fact sheet: obesity and overweight. Available at http://www.who.int/mediacentre. Accessed on: 11 Jun. 2008

  2. Oeser A, Chung CP, Asanuma Y, Avalos I, Stein M (2005) Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arthritis Rheum 52(11):3651–3659

    Article  PubMed  CAS  Google Scholar 

  3. Chaiamnuay S, Bertoli AM, Fernández M, Apte M, Vilá LM, LUMINA Study Group et al (2007) The impact of increased body mass index on systemic lupus erythematosus. J Clin Rheumatol 13(3):128–133

    Article  PubMed  Google Scholar 

  4. Petri M (2000) Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 9:170–175

    Article  PubMed  CAS  Google Scholar 

  5. Lee S–S, Singh S, Magder LS, Petri M (2008) Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus. Lupus 17:114–123

    Article  PubMed  CAS  Google Scholar 

  6. Bultink IEM (2010) Prospective cohort studies on risk factors for cardiovascular events in systemic lupus erythematosus: a major challenge. Arthritis Res Ther 12(107–108):107

    Article  PubMed  Google Scholar 

  7. Tan EM, Cohen AS, Fries JF (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982(25):1271–1277

    Article  Google Scholar 

  8. Hochberg MC (1997) Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  PubMed  CAS  Google Scholar 

  9. Onis M, Habicth JP (1996) Anthropometric reference data for international use: recommendations from a world health organization expert committee health organization. Am J Clin Nutr 64:650–658

    PubMed  Google Scholar 

  10. Luiz RA, Magnanimi MMF (2004) Size of samples in epidemiological investigations In: Medronho R. Epidemiologia. 2a ed. São Paulo: Atheneu. Cap.10, p 415–427

  11. V Brazilian Guidelines on Hypertension. Arq Bras Cardiol 2007;89(3):e24–e79

    Google Scholar 

  12. American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 27:S5–S10

    Article  Google Scholar 

  13. Lawrence NM (2009) Primary ovarian insufficiency. N Engl J Med 360(6):606–614

    Article  Google Scholar 

  14. Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288–291

    PubMed  Google Scholar 

  15. Gladman DD, Ginzler EM, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369

    Article  PubMed  CAS  Google Scholar 

  16. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395

    Article  PubMed  Google Scholar 

  17. Matsudo SM, Araújo T, Matsudo VR, Andrade D, Andrade E, Oliveira LC et al (2001) International physical activity questionnaire (IPAQ): reproducibility and validity study in Brazil. Rev Bras Física Saúde 6:5–18

    Google Scholar 

  18. Celafisc (2007) Physical activity classification—IPAQ. Brazil. Available at: http://www.celafisc.institucional.ws/65/questionarios.html. Accessed on 9 Sep. 2009

  19. Bernatsky S, Biovin JF, Josefh L, Pierre YST, Moore A, Rajan R et al (2002) Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issue, and obesity. J Rheumatol 29:2551–2554

    PubMed  Google Scholar 

  20. Ministry of Health. Surveillance and risk factors for chronic disease through telephone interviews. Brazil; 2008. Available at: http://www.saude.gov.br. Accessed on 2 Nov. 2009

  21. Telles RW, Lanna CCD, Ferreira GA, Carvalho MA, Ribeiro AL (2007) Frequency of atherosclerotic cardiovascular disease and its risk factors in patients with systemic lupus erythematosus. Rev Bras Reumatol 47(3):165–172

    Article  Google Scholar 

  22. Haas E, Bhattacharya I, Brailoiu E, Damjanovic M, Brailoiu CG, Gao X et al (2009) Regulatory role of G protein coupled estrogen receptor for vascular function and obesity. Circ Res 104:288–291

    Article  PubMed  CAS  Google Scholar 

  23. Williamson DF, Kahn HS, Remington PL, Anda RF (1990) The 10-year incidence of overweight and major weight gain in US adults. Arch Intern Med 150:665–672

    Article  PubMed  CAS  Google Scholar 

  24. Jeffey RW, French SA (1996) Socioeconomic status and weight control practices among 20- to 45-year-old women. Am J Public Health 86(7):1005–1010

    Article  Google Scholar 

  25. Alarcón GS, McGwin GJr, Bastian HM, Roseman J, Lisse J, Fessler BJ et al (2001) for the Lumina study group Systemic Lupus Erythematosus in Three Ethnic Groups. VIII. Predictors of Early Mortality in the LUMINA Cohort. Arthritis Rheum 45(2):191–202

  26. Sabio JM, Zamora-Pasadas M, Jiménez-Jáimez J, Albadalejo F, Vargas-Hitos J et al (2008) Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain. Lupus 17:849–859

    Article  PubMed  CAS  Google Scholar 

  27. Bellomio V, Spindler A, Lucero E, Berman A, Sueldo R et al (2009) Metabolic syndrome in Argentinean patients with systemic lupus erythematosus. Lupus 18:1019–1025

    Article  PubMed  CAS  Google Scholar 

  28. Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513–519

    Article  PubMed  CAS  Google Scholar 

  29. Cardoso CRL, Signorelli F, Papi JA, Salles GF (2008) Prevalence and factors associated with dyslipoproteinemias in Brazilian systemic lupus erythematosus patients. Reumatol Int 28:323–327

    Article  Google Scholar 

  30. Petri M (1996) Hydroxychloroquine used in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus 5:S16–S22

    Article  PubMed  CAS  Google Scholar 

  31. Borba EF, Bonfa E (2001) Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy. J Rheumatol 28:780–785

    PubMed  CAS  Google Scholar 

  32. Fessler BJ, Alarcón G, McGwin Jr G, LUMINA Study Group et al (2005) Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum 52:1473–1480

  33. Irastorza RG, Egurbide MV, Pijoan JI, Garmendia M, Villar I, Berrriota MA et al (2006) Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 15:577–583

    Article  Google Scholar 

  34. Fortin PR, Abrahamowic M, Ferland D, Lacaille D, Smith CD, Zummer M (2008) Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 59(13):1796–1804

    Article  PubMed  CAS  Google Scholar 

  35. Wong JM, Esdaile JM (2005) Methotrexate in systemic lupus erythematosus. Lupus 14:101–105

    Article  PubMed  CAS  Google Scholar 

  36. Sánchez Y, Carvallo A (2004) Methotrexate use in patients with systemic lupus erythematosus. Rev Méd Chile 132:195–201

    PubMed  Google Scholar 

  37. Ogden CL, Carroll M, Curtin LR, McDowell MA, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555

    Article  PubMed  CAS  Google Scholar 

  38. Kunitoshi I, Yoshiharu I, Kozen K, Taku I, Chiho I, Shuichi T (2004) Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65:1870–1876

    Article  Google Scholar 

  39. Tench CM, McCarthy J, McCurdie I, White PD, Cruz DPD (2003) Fatigue is systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology 42:1050–1054

    Article  PubMed  CAS  Google Scholar 

  40. Carvalho MRP, Sato E, Tebexreni AS, Heidecher RTC, Schenkman S, Neto TLB (2005) Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity and quality of life in patients with systemic lupus erythematosus. Arthritis Rheum 53:838–844

    Article  PubMed  Google Scholar 

  41. Ayán C, Martín V (2007) Systemic lupus erythematosus and exercise. Lupus 16:5–8

    Article  PubMed  Google Scholar 

  42. Tench C, Bentley D, Vleck V, Mccurdie I, White P, D’Cruz D (2002) Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus. J Rheumatol 29:474–481

    PubMed  Google Scholar 

Download references

Acknowledgments

We acknowledge the FAPEMIG (The State of Minas Gerais Research Foundation) for financial support and the CNPQ (Conselho Nacional de Desenvolvimento Científico e Tecnológico) for the research grant to Correia, MITD.

Conflict of interest

None of the authors has declared a conflict of interest.

Author information

Authors and Affiliations

  1. Rheumatology Service, Hospital das Clínicas, Department of Locomotor System, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

    Fabiana de Miranda Moura dos Santos, Rosa Weiss Telles & Cristina Costa Duarte Lanna

  2. School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

    Mariane Curado Borges

  3. Department of Surgery, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

    Maria Isabel T. D. Correia

  4. Department of Locomotor System, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

    Cristina Costa Duarte Lanna

Authors
  1. Fabiana de Miranda Moura dos Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mariane Curado Borges
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rosa Weiss Telles
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Isabel T. D. Correia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cristina Costa Duarte Lanna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mariane Curado Borges.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Miranda Moura dos Santos, F., Borges, M.C., Telles, R.W. et al. Excess weight and associated risk factors in patients with systemic lupus erythematosus. Rheumatol Int 33, 681–688 (2013). https://doi.org/10.1007/s00296-012-2402-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2402-8

Keywords

Search

Navigation